Cargando…

Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome()

BACKGROUND: High plasma levels of Lp(a) are associated with a worse prognosis in patients with coronary artery disease. The aim of the present study is to clarify the association between high lipoprotein a [Lp(a)] levels and vulnerable characteristics of nonculprit plaques in patients with acute cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Ayami, Kinoshita, Daisuke, Nagata, Takako, Asakura, Kiyoshi, Katamine, Masahiro, Katsura, Aritomo, Hashimoto, Takuya, Minami, Yoshiyasu, Ako, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474856/ https://www.ncbi.nlm.nih.gov/pubmed/36118156 http://dx.doi.org/10.1016/j.ijcha.2022.101120

Ejemplares similares

Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study
por: Muramatsu, Yusuke, et al.
Publicado: (2019)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Gender differences in plaque characteristics of nonculprit lesions in patients with coronary artery disease
por: Tian, Jiangtian, et al.
Publicado: (2019)

Interventional Treatment of Nonculprit Lesions in Infarct‐Related Cardiogenic Shock
por: Desch, Steffen, et al.
Publicado: (2019)

Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study
por: Zhang, Donghui, et al.
Publicado: (2018)

Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET/CT
por: Derlin, Thorsten, et al.
Publicado: (2018)

Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion
por: Kang, Jeehoon, et al.
Publicado: (2016)

The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography
por: Kang, Jeehoon, et al.
Publicado: (2018)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI
por: Don, Creighton W., et al.
Publicado: (2022)

Lower limb ischemia due to popliteal artery compression by Baker cyst
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2018)

Vascular response and intrastent thrombus in the early phase after drug‐eluting versus bare‐metal stent implantation in patients with ST‐segment elevation myocardial infarction: An observational, single‐center study
por: Sato, Nobuhiro, et al.
Publicado: (2018)

Tako-tsubo-like left ventricular dysfunction in a patient with COVID-19 demonstrated by non-invasive multi-modality imaging
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2020)

Very late stent thrombosis lacking findings of the typical causes on optical coherence tomography in a patient with SARS-CoV-2
por: Shinkai, Wataru, et al.
Publicado: (2022)

Neuroimaging of the Vulnerable Plaque
por: Lovblad, Karl-Olof, et al.
Publicado: (2015)

Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study
por: Yuan, Xiaohang, et al.
Publicado: (2022)

Left Ventricular Contraction Sequence in a Case Where the QRS Changed from Left to Atypical Right Bundle Branch Block
por: Hara, Hideyuki, et al.
Publicado: (2020)

Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy)
por: Thim, Troels, et al.
Publicado: (2020)

Effect of cardiac rehabilitation on cognitive function in elderly patients with cardiovascular diseases
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2020)

Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease
por: Niccoli, Giampaolo, et al.
Publicado: (2016)

Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Kim, Inna, et al.
Publicado: (2017)

Effect of ramipril on progression of nonculprit lesions in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention
por: Wang, Jian, et al.
Publicado: (2019)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Myocardial ischemia induced by major aortopulmonary collateral arteries treated with transcatheter coil embolization
por: Kakizaki, Ryota, et al.
Publicado: (2017)

Role of lipoprotein(a) in plaque progression
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A(2) in human vulnerable atherosclerotic plaque
por: Li, Jingjin, et al.
Publicado: (2021)

Rapid progression of nonculprit coronary lesions six weeks after successful primary PCI in culprit artery: a case report
por: Tang, Jianjin, et al.
Publicado: (2014)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Intraplaque haemorrhages as the trigger of plaque vulnerability
por: Michel, Jean-Baptiste, et al.
Publicado: (2011)

Intracoronary Imaging in the Detection of Vulnerable Plaques
por: Batty, Jonathan A., et al.
Publicado: (2016)

Noninvasive diagnosis of vulnerable coronary plaque
por: Pozo, Eduardo, et al.
Publicado: (2016)

Gender Differences of Plaque Characteristics in Elderly Patients with Stable Angina Pectoris: An Intravascular Ultrasonic Radiofrequency Data Analysis
por: Nakamura, Tomohiro, et al.
Publicado: (2010)

Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes
por: Yamamoto, Erika, et al.
Publicado: (2019)

Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial
por: Biscaglia, Simone, et al.
Publicado: (2020)

The Spatial Distribution of Plaque Vulnerabilities in Patients with Acute Myocardial Infarction
por: Zheng, Guian, et al.
Publicado: (2016)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
por: Shindo, Akihiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e93sed1i6pb2kaseljnmphaer9